Alzheimer's Disease: From Pathogenesis to Disease-Modifying Approaches

E-ISSN： 1996-3181|10|2|163-174

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.2, 2011-03, pp. : 163-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease-Modifying Approach to the Treatment of Alzheimer's Disease: From α-Secretase Activators to γ-Secretase Inhibitors and Modulators

By Panza Francesco

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 537-555

Adis International

Access to resources Recommend Favorite

Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease

By Beher Dirk Graham Samuel L

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1385-1409

Informa Healthcare

Access to resources Recommend Favorite

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease

By Van Dam Debby Coen Katrien De Deyn Peter

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 37-43

Springer Publishing Company

Access to resources Recommend Favorite

Disease-Modifying Therapies in Alzheimer's Disease: How Far Have We Come?

By Hüll Michael Berger Mathias

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2075-2093

Adis International

Access to resources Recommend Favorite

Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer's Disease?

By Giacobini E.

CNS Drugs, Vol. 15, Iss. 2, 2001-01 ,pp. : 85-91

Adis International

Access to resources Recommend Favorite